Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Return on Sales (2016 - 2025)

Wave Life Sciences' Return on Sales history spans 11 years, with the latest figure at 11.43% for Q4 2025.

  • For Q4 2025, Return on Sales fell 1158.0% year-over-year to 11.43%; the TTM value through Dec 2025 reached 11.43%, down 1102.0%, while the annual FY2025 figure was 4.78%, 389.0% down from the prior year.
  • Return on Sales reached 11.43% in Q4 2025 per WVE's latest filing, down from 0.56% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.15% in Q3 2023 to a low of 136.86% in Q3 2022.
  • Average Return on Sales over 5 years is 15.9%, with a median of 1.9% recorded in 2023.
  • Peak YoY movement for Return on Sales: tumbled -13669bps in 2022, then skyrocketed 13700bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.45% in 2021, then decreased by -21bps to 0.54% in 2022, then skyrocketed by 76bps to 0.13% in 2023, then skyrocketed by 216bps to 0.15% in 2024, then crashed by -7898bps to 11.43% in 2025.
  • Per Business Quant, the three most recent readings for WVE's Return on Sales are 11.43% (Q4 2025), 0.56% (Q3 2025), and 5.8% (Q2 2025).